National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Childhood Central Nervous System Embryonal Tumors (PDQ®)     
Last Modified: 04/03/2008
Health Professional Version
Purpose of This PDQ Summary

This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of childhood central nervous system embryonal tumors. This summary is reviewed regularly and updated as necessary by the PDQ Pediatric Treatment Editorial Board 1.

Information about the following is included in this summary:

  • Cellular classification of central nervous system embryonal tumors.
  • Stage information and treatment options for:
    • Medulloblastoma.
    • Pineoblastoma and pineal parenchymal tumors of intermediate differentiation.
    • Supratentorial primitive neuroectodermal tumors.
    • Medulloepithelioma.
    • Ependymoblastoma.

This summary is intended as a resource to inform and assist clinicians and other health professionals who care for pediatric cancer patients. It does not provide formal guidelines or recommendations for making health care decisions.

In the summary, treatments are described as “standard” or “conventional” and “under clinical evaluation.” These designations should not be used as a basis for reimbursement determinations.

This summary will also soon be available in a patient version, which is written in less-technical language, and in a Spanish version.



Table of Links

1http://www.cancer.gov/cancerinfo/pdq/pediatric-treatment-board